These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36761735)

  • 21. TLR8 combined withTLR3 or TLR4 agonists enhances DC-NK driven effector Tc1 cells.
    Nouri-Shirazi M; Tamjidi S; Nourishirazi E; Guinet E
    Immunol Lett; 2018 Jan; 193():58-66. PubMed ID: 29103998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.
    Tada H; Aiba S; Shibata K; Ohteki T; Takada H
    Infect Immun; 2005 Dec; 73(12):7967-76. PubMed ID: 16299289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternaria inhibits double-stranded RNA-induced cytokine production through Toll-like receptor 3.
    Wada K; Kobayashi T; Matsuwaki Y; Moriyama H; Kita H
    Int Arch Allergy Immunol; 2013; 161 Suppl 2(0 2):75-83. PubMed ID: 23711857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytosolic dsRNA improves neonatal innate immune responses to adjuvants in use in pediatric vaccines.
    Brennan K; Craven S; Cheung M; Kane D; Noone E; O'Callaghan J; Molloy EJ; Walsh PT; McAuliffe FM; Doyle SL
    J Leukoc Biol; 2022 Sep; 112(3):523-537. PubMed ID: 35098572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune Adjuvant Targeting Micelles Allow Efficient Dendritic Cell Migration to Lymph Nodes for Enhanced Cellular Immunity.
    Yang X; Lian K; Meng T; Liu X; Miao J; Tan Y; Yuan H; Hu F
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):33532-33544. PubMed ID: 30192498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity.
    Ohmura-Hoshino M; Yamamoto M; Yuki Y; Takeda Y; Kiyono H
    Vaccine; 2004 Sep; 22(27-28):3751-61. PubMed ID: 15315856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice.
    Salem ML; Diaz-Montero CM; El-Naggar SA; Chen Y; Moussa O; Cole DJ
    Vaccine; 2009 Jan; 27(4):549-57. PubMed ID: 19027047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
    Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ
    J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant.
    Engel AL; Sun GC; Gad E; Rastetter LR; Strobe K; Yang Y; Dang Y; Disis ML; Lu H
    Immunobiology; 2013 Dec; 218(12):1468-76. PubMed ID: 23735481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells.
    Volckmar J; Knop L; Stegemann-Koniszewski S; Schulze K; Ebensen T; Guzmán CA; Bruder D
    Vaccine; 2019 Aug; 37(35):4963-4974. PubMed ID: 31320219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvanticity of aqueous extracts of Artemisia rupestris L. for inactivated foot-and-mouth disease vaccine in mice.
    Wang D; Cao H; Li J; Zhao B; Wang Y; Zhang A; Huang J
    Res Vet Sci; 2019 Jun; 124():191-199. PubMed ID: 30913435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological adjuvant effect of Boswellia serrata (BOS 2000) on specific antibody and cellular response to ovalbumin in mice.
    Gupta A; Khajuria A; Singh J; Singh S; Suri KA; Qazi GN
    Int Immunopharmacol; 2011 Aug; 11(8):968-75. PubMed ID: 21371582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy.
    Schülke S; Burggraf M; Waibler Z; Wangorsch A; Wolfheimer S; Kalinke U; Vieths S; Toda M; Scheurer S
    J Allergy Clin Immunol; 2011 Dec; 128(6):1340-1348.e12. PubMed ID: 21872305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunostimulatory activity of water-extractable polysaccharides from Cistanche deserticola as a plant adjuvant in vitro and in vivo.
    Zhang A; Yang X; Li Q; Yang Y; Zhao G; Wang B; Wu D
    PLoS One; 2018; 13(1):e0191356. PubMed ID: 29360858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C).
    Wick DA; Martin SD; Nelson BH; Webb JR
    Vaccine; 2011 Jan; 29(5):984-93. PubMed ID: 21115055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR3-Mediated CD8+ Dendritic Cell Activation Is Coupled with Establishment of a Cell-Intrinsic Antiviral State.
    Széles L; Meissner F; Dunand-Sauthier I; Thelemann C; Hersch M; Singovski S; Haller S; Gobet F; Fuertes Marraco SA; Mann M; Garcin D; Acha-Orbea H; Reith W
    J Immunol; 2015 Aug; 195(3):1025-33. PubMed ID: 26101320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TLR7 imidazoquinoline ligand 3M-019 is a potent adjuvant for pure protein prototype vaccines.
    Johnston D; Zaidi B; Bystryn JC
    Cancer Immunol Immunother; 2007 Aug; 56(8):1133-41. PubMed ID: 17139492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-Stranded Structure of the Polyinosinic-Polycytidylic Acid Molecule to Elicit TLR3 Signaling and Adjuvant Activity in Murine Intranasal A(H1N1)pdm09 Influenza Vaccination.
    Nakano T; Ohara Y; Fujita H; Ainai A; Yamamura ET; Suzuki T; Hasegawa H; Sone T; Asano K
    DNA Cell Biol; 2020 Sep; 39(9):1730-1740. PubMed ID: 32580635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
    Verma V; Tan W; Puth S; Cho KO; Lee SE; Rhee JH
    J Transl Med; 2016 May; 14(1):135. PubMed ID: 27184355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.